Autologous stimulation of human lymphocyte subpopulation.

PubWeight™: 4.80‹?› | Rank: Top 1%

🔗 View Article (PMC 2189968)

Published in J Exp Med on November 01, 1975

Authors

G Opelz, M Kiuchi, M Takasugi, P I Terasaki

Articles citing this

Clonal analysis of human cytotoxic T lymphocytes: T4+ and T8+ effector T cells recognize products of different major histocompatibility complex regions. Proc Natl Acad Sci U S A (1982) 5.85

Contribution of dendritic cells to stimulation of the murine syngeneic mixed leukocyte reaction. J Exp Med (1980) 5.50

Lymphocyte transformation induced by autologous cells. IV. Human T-lymphocyte proliferation induced by autologous or allogeneic non-T lymphocytes. J Exp Med (1976) 4.63

Lymphocyte transformation induced by autologous cells. V. Generation of immunologic memory and specificity during the autologous mixed lymphocyte reaction. J Exp Med (1977) 3.06

Failure of autologous mixed lymphocyte reactions between T and non-T cells in patients with systemic lupus erythematosus. Proc Natl Acad Sci U S A (1978) 2.94

Autologous mixed lymphocyte culture reactions and generation of cytotoxic T cells. J Exp Med (1977) 2.66

Human dendritic cells: major stimulators of the autologous and allogeneic mixed leucocyte reactions. Clin Exp Immunol (1982) 2.41

Specificity and function of a human autologous reactive T cell. J Exp Med (1979) 2.37

Monoclonal antibody analysis of human T lymphocyte subpopulations exhibiting autologous mixed lymphocyte reaction. Proc Natl Acad Sci U S A (1981) 2.16

Production of autoreactive I region-restricted T cell hybridomas. J Exp Med (1982) 1.70

The cellular basis of the impaired autologous mixed lymphocyte reaction in patients with systemic lupus erythematosus. J Clin Invest (1979) 1.67

Murine syngeneic mixed lymphocyte response. I. Target antigens are self Ia molecules. J Exp Med (1981) 1.65

Induction of suppressor activity in the autologous mixed lymphocyte reaction and in cultures with concanavalin A. J Clin Invest (1979) 1.52

Delineation of an immunoregulatory amplifier population recognizing autologous Ia molecules. Analysis with human T cell clones. J Exp Med (1984) 1.49

Autologous rosette-forming T cells as the responding cells in human autologous mixed-lymphocyte reaction. J Clin Invest (1980) 1.41

Responder cells in the human autologous mixed lymphocyte reaction. J Clin Invest (1981) 1.37

Demonstration of the inhibitory effect of human alpha-fetoprotein on in vitro transformation of human lymphocytes. Proc Natl Acad Sci U S A (1976) 1.37

Role of T lymphocytes in cellular immune responses during herpes simplex virus infection in humans. Proc Natl Acad Sci U S A (1978) 1.35

Autologous leukemia-specific T-cell-mediated lymphocytotoxicity in patients with acute myelogenous leukemia. J Exp Med (1978) 1.29

Lymphocyte transformation induced by autologous cells. VIII. Impaired autologous mixed lymphocyte reactivity in patients with acute infectious mononucleosis. J Exp Med (1979) 1.21

In vitro induction of cytotoxic effector cells with spontaneous killer cell specificity. J Exp Med (1978) 1.19

Autologous mixed lymphocyte reaction in patients with Hodgkin's disease. Evidence for a T cell defect. J Clin Invest (1980) 1.19

Activation of immune regulatory circuits among OKT4+ cells by autologous mixed lymphocyte reactions. Clin Exp Immunol (1984) 1.12

Generation of autologous mixed leucocyte reactions during the course of infection with Theileria parva (East Coast Fever) in cattle. Immunology (1980) 1.08

Deficiency of the autologous mixed lymphocyte reaction in patients with primary biliary cirrhosis. J Clin Invest (1980) 1.07

In vitro synthesis of IgE by human peripheral blood leucocytes. II modulation of IgE B cell activity by isotype-specific regulatory T cells. Clin Exp Immunol (1981) 1.07

Antigen-reactive T cells can be activated buy autologous macrophages in the absence of added antigen. J Exp Med (1981) 1.01

Disordered immunoregulatory functions in patients with chronic active hepatitis. Clin Exp Immunol (1982) 1.00

Interleukin-2 activity in chronic active liver diseases: response by T cells and in the autologous mixed lymphocyte reaction. Clin Exp Immunol (1984) 0.96

Immunological T-cell memory in the in vitro-induced experimental autoimmune orchitis: specificity of the reaction and tissue distribution of the autoantigens. J Exp Med (1978) 0.96

Production of a cytokine with interleukin 3-like properties and cytokine-dependent proliferation in human autologous mixed lymphocyte reaction. J Exp Med (1986) 0.95

Generation of suppressor cells in the autologous mixed lymphocyte reaction. Clin Exp Immunol (1981) 0.94

Deficient autologous mixed lymphocyte reactions correlate with disease activity in systemic lupus erythematosus and rheumatoid arthritis. Clin Exp Immunol (1982) 0.94

Deficiency of the autologous mixed lymphocyte reaction in patients with classic hemophilia treated with commercial factor VIII concentrate. Correlation with T cell subset distribution, antibodies to lymphadenopathy-associated or human T lymphotropic virus, and analysis of the cellular basis of the deficiency. J Clin Invest (1985) 0.93

Properties of reticulum cell sarcomas in SJL/J mice. V. Nature of reticulum cell sarcoma surface antigen which induces proliferation of normal SJL/J T cells. J Exp Med (1977) 0.92

The enhancement of eosinophil function by lymphocyte supernatants. Clin Exp Immunol (1983) 0.90

Helper cells in the autologous mixed lymphocyte reaction. III. Production of helper factor(s) distinct from interleukin 2. J Exp Med (1982) 0.90

The distribution and functional properties of dendritic cells in patients with seronegative arthritis. Clin Exp Immunol (1991) 0.90

Enhancement of the impaired autologous mixed leukocyte reaction in patients with systemic lupus erythematosus. J Clin Invest (1985) 0.89

Origin and specificity of autoreactive T cells in antigen-induced populations. J Exp Med (1985) 0.87

Studies on the syngeneic mixed lymphocyte reaction. III. Development of a monoclonal antibody with specificity for autoreactive T cells. J Exp Med (1983) 0.86

Impaired autologous mixed-lymphocyte reaction of peripheral blood lymphocytes in adult periodontitis. Infect Immun (1991) 0.86

Adherent Ia+ murine tumor lines with characteristics of dendritic cells. I. Morphology, surface phenotype, and induction of syngeneic mixed lymphocyte reactions. J Exp Med (1981) 0.86

Human autologous mixed lymphocyte reaction as an in vitro model for autoreactivity to apoptotic antigens. Immunology (2002) 0.85

Lack of correlation between lymphocyte activating determinants and HLA-DR on acute leukaemias. Br J Cancer (1984) 0.85

Superantigen-mediated differentiation of bovine monocytes into dendritic cells. J Leukoc Biol (2009) 0.83

Defective autologous mixed lymphocyte reactivity in multiple sclerosis. Clin Exp Immunol (1986) 0.82

Generation and regulation of autocytotoxicity in mixed lymphocyte cultures: evidence for active suppression of autocytotoxic cells. Proc Natl Acad Sci U S A (1985) 0.82

The role of autoreactive T-cell hybridomas from autoimmune model mice. Immunology (1988) 0.81

Factors influencing the autologous mixed lymphocyte reaction in rats: effect of xenogeneic serum protein. Immunology (1981) 0.81

Responses of canine lymphocytes to allogeneic and autologous Islets of Langerhans in mixed cell cultures. J Clin Invest (1981) 0.80

Impaired autologous mixed lymphocyte reaction (AMLR) reactivity of peripheral blood T cell subsets in rheumatoid arthritis. Clin Exp Immunol (1989) 0.80

Factors affecting the autologous mixed lymphocyte reaction in kidney transplantation. J Clin Invest (1983) 0.80

Inhibition of proliferative and suppressor responses in the autologous mixed lymphocyte reaction by serum from patients with systemic lupus erythematosus. Ann Rheum Dis (1982) 0.80

T cell proliferation induced by anti-self-I-A-specific T cell hybridomas. Evidence of a T cell network. J Exp Med (1986) 0.79

Dependence of lymphocyte surface Ig on continuous polyclonal activation. Immunology (1979) 0.79

In vitro proliferation of macrophage depleted human peripheral blood lymphocytes. Clin Exp Immunol (1979) 0.78

Immunoglobulin production in the autologous MLR: target of the suppressor-amplifier circuit. Clin Exp Immunol (1986) 0.78

Frequency in human peripheral blood of T cells which respond to self, modified self and alloantigens. Immunology (1983) 0.78

Cell-mediated immune responses between HLA-identical siblings: recognition of antigenic changes associated with acute myelogenous leukaemia. Clin Exp Immunol (1980) 0.78

T-suppressor clones derived from murine AMLR. Immunology (1985) 0.78

The blastogenic response of rabbit lymphocytes stimulated with autologous cells. Immunology (1979) 0.77

Blastogenic response of purified human T-lymphocyte populations to Epstein-Barr virus (EBV). Clin Exp Immunol (1977) 0.76

Autologous mixed lymphocyte reaction in the peripheral blood and pleural effusions of cancer patients. J Clin Invest (1982) 0.76

Autologous rosette-forming T cells regulate responses of T cells. Phenotypic and functional analysis of suppressor cells generated from autologous rosette-forming T cells after autologous mixed lymphocyte reactions. J Clin Invest (1981) 0.75

Evidence of cell-mediated immune contrasuppression in lepromatous leprosy: modulation of a putative T contrasuppressor cell-subset. Clin Exp Immunol (1988) 0.75

Inhibition of autologous mixed lymphocyte reaction by monoclonal antibodies specific for the beta chain of HLA-DR antigens. Immunology (1984) 0.75

Surface antigens in acute myeloblastic leukaemia: a study using heterologous antisera. Br J Cancer (1978) 0.75

CD8+/DR+ T gamma cells inhibit the autologous mixed lymphocyte reaction. Clin Exp Immunol (1990) 0.75

Cellular interactions in spontaneous or autologous cell-induced proliferative and lymphokine responses of human lymphocytes. Immunology (1980) 0.75

Studies of proliferative responses by long-term-cryopreserved peripheral blood mononuclear cells to bacterial components associated with periodontitis. Clin Diagn Lab Immunol (1996) 0.75

AMLR and MLR stimulating activity of human T lymphocytes activated in vitro by soluble HLA-DR antigens. Clin Exp Immunol (1986) 0.75

Chronic lymphocytic leukemia: temporal changes in numbers of T-lymphocytes. Can Med Assoc J (1980) 0.75

Failure to detect autologous antibodies in the remission sera of patients with AML: complications introduced by the presence of rheumatoid factor. Br J Cancer (1980) 0.75

Proliferation of alloantigen sensitized human peripheral blood lymphocytes by autologous cells associated with the HLA-B8/DR3. Clin Exp Immunol (1982) 0.75

Articles cited by this

Surface markers on human B and T lymphocytes. II. Presence of Epstein-Barr virus receptors on B lymphocytes. J Exp Med (1973) 5.03

Cytotoxins in disease. Autocytotoxins in lupus. N Engl J Med (1970) 4.40

Stimulation of lymphocytes by autologous leukaemic cells in acute leukaemia. Nature (1969) 2.75

Expression of human T and B lymphocyte cell-surface markers on leukaemic cells. Lancet (1974) 2.15

Stimulatory capacity of human T and B lymphocytes in the mixed leukocyte culture. Nature (1974) 2.09

A semimicro mixed leukocyte culture test. Transplantation (1971) 1.85

Mixed leukocyte stimulation of normal peripheral leukocytes by autologous lymphoblastoid cells. Science (1970) 1.79

A unique 'leukaemic' T lymphoid cell line: absence of stimulating effect in mixed lymphocyte reaction. Lack of MLR-S in leukaemic T lymphoid cells. Clin Exp Immunol (1973) 1.59

Immunoglobulin on tumor cells and tumor-induced lymphocyte blastogenesis in human acute leukemia. N Engl J Med (1973) 1.57

Lymphocyte cytotoxicity reactions to leukemia-associated antigens in identical twins. Int J Cancer (1972) 1.55

The thymus in myasthenia gravis. Evidence for altered cell populations. N Engl J Med (1974) 1.50

Immune reactivity of leukemia patients to autologous blast cells. Cancer Res (1972) 1.24

Lymphocyte activation: a rapid test to predict allograft rejection. Nature (1970) 1.22

Serum-mediated inhibition of lymphocyte stimulation by autochthonous human tumors. J Natl Cancer Inst (1971) 1.22

Leukocyte iso- and autoantibodies in multiple sclerosis (MS) with special regard to complement-dependent cold-reacting auto-lymphocytotoxins (CoCoCy). Eur Neurol (1972) 1.14

Lymphocyte receptors for autoantigens, autologous serum inhibits self-recognition. Nat New Biol (1973) 1.04

Inhibition of tumor-induced lymphocyte blastogenesis by a factor or factors associated with peripheral leukocytes. Science (1974) 1.02

Articles by these authors

High association of an HL-A antigen, W27, with ankylosing spondylitis. N Engl J Med (1973) 9.90

Serotyping for homotransplantation. 18. Refinement of microdroplet lymphocyte cytotoxicity test. Transplantation (1968) 8.51

The use of cyclosporin A and prednisone in cadaver kidney transplantation. Surg Gynecol Obstet (1980) 7.40

Microdroplet testing for HLA-A, -B, -C, and -D antigens. The Phillip Levine Award Lecture. Am J Clin Pathol (1978) 6.88

Significance of the positive crossmatch test in kidney transplantation. N Engl J Med (1969) 5.50

Cytotoxins in disease. Autocytotoxins in lupus. N Engl J Med (1970) 4.40

A microassay for cell-mediated immunity. Transplantation (1970) 4.29

Serotyping for homotransplantation. X. Survival of 196 grafted kidneys subsequent to typing. Transplantation (1967) 4.16

Shwartzman reaction after human renal homotransplantation. N Engl J Med (1968) 4.05

Kidney preservation for transportation. Initial perfusion and 30 hours' ice storage. Lancet (1969) 3.67

Long-term survival after renal transplantation in humans: (with special reference to histocompatibility matching, thymectomy, homograft glomerulonephritis, heterologous ALG , AND RECIPIENT MALIGNANCY). Ann Surg (1970) 3.48

Effect of blood transfusions on subsequent kidney transplants. Transplant Proc (1973) 3.42

Chimerism after liver transplantation for type IV glycogen storage disease and type 1 Gaucher's disease. N Engl J Med (1993) 3.36

Nomenclature for factors of the HLA system, 2010. Tissue Antigens (2010) 3.22

Effect of pravastatin on outcomes after cardiac transplantation. N Engl J Med (1995) 3.11

Chronic survival after human renal homotransplantation. Lymphocyte-antigen matching, pathology and influence of thymectomy. Ann Surg (1965) 3.00

Improvement of kidney-graft survival with increased numbers of blood transfusions. N Engl J Med (1978) 2.52

Incidence of de-novo breast cancer in women chronically immunosuppressed after organ transplantation. Lancet (1995) 2.50

Transplantation of kidneys from donors whose hearts have stopped beating. N Engl J Med (1998) 2.48

Association of primary sclerosing cholangitis with HLA-DRw52a. N Engl J Med (1990) 2.40

Thoracic duct drainage before and after cadaveric kidney transplantation. Surg Gynecol Obstet (1979) 2.33

Heterologous antilymphocyte glubulin, histoincompatiblity matching, and human renal homotransplantation. Surg Gynecol Obstet (1968) 2.23

The relative effects of FK506 and cyclosporine on short- and long-term kidney graft survival. Transplantation (1995) 2.13

Influence of test technique on sensitization status of patients on the kidney transplant waiting list. Am J Transplant (2013) 2.12

Equitable allocation of HLA-compatible kidneys for local pools and minorities. N Engl J Med (1994) 2.12

Reactivity of lymphocytes from normal persons on cultured tumor cells. Cancer Res (1973) 2.11

Survival of nationally shared, HLA-matched kidney transplants from cadaveric donors. The UNOS Scientific Renal Transplant Registry. N Engl J Med (1992) 2.09

Human renal transplants. I. Glomerular changes. Lab Invest (1967) 2.06

Characterization of sialosylated Lewisx as a new tumor-associated antigen. Cancer Res (1984) 2.02

[Immunological aspects of kidney transplantation in Switzerland 1981-1992. Swiss Transplant Work Group Kidney Transplantation]. Schweiz Med Wochenschr (1995) 1.91

Oligodeoxynucleotides covalently linked to intercalating agents: a new class of gene regulatory substances. Biochimie (1986) 1.90

Nomenclature for factors of the HLA system, 2002. Tissue Antigens (2002) 1.89

Analysis of HL-A incompatibility in human renal transplants. Tissue Antigens (1971) 1.89

Oligo(alpha-deoxynucleotide)s covalently linked to intercalating agents: differential binding to ribo- and deoxyribopolynucleotides and stability towards nuclease digestion. Proc Natl Acad Sci U S A (1987) 1.88

A semimicro mixed leukocyte culture test. Transplantation (1971) 1.85

Juvenile myoclonic epilepsy (JME) may be linked to the BF and HLA loci on human chromosome 6. Am J Med Genet (1988) 1.82

Serotyping for homotransplantation. V. Evaluation of a matching scheme. Transplantation (1966) 1.78

Enhancement of human kidney allografts by cold B-lymphocyte cytotoxins. Lancet (1978) 1.70

Spinocerebellar ataxia and HLA linkage: risk prediction by HLA typing. N Engl J Med (1977) 1.67

Multiple sclerosis: association with HL-A3. Tissue Antigens (1972) 1.65

Successful renal allografts across a positive cross-match for donor B-lymphocyte alloantigens. Lancet (1976) 1.63

Disturbance of HL-A antigen frequency in Psoriasis. N Engl J Med (1972) 1.63

Cross reactions between human transplantation antigens and bacterial lipopolysaccharides. Transplantation (1973) 1.60

Thoracic duct fistula and renal transplantation. Ann Surg (1979) 1.60

Influence of race on kidney transplant survival. Transplant Proc (1977) 1.58

Increased prevalence of W27 in juvenile rheumatoid arthritis. N Engl J Med (1974) 1.58

Treatment of lymphopenic hypogammaglobulinemia and bone-marrow aplasia by transplantation of allogeneic marrow. Crucial role of histocompatiility matching. N Engl J Med (1969) 1.58

Selecting donors of platelets for refractory patients on the basis of HLA antibody specificity. Transfusion (2000) 1.58

Nomenclature for factors of the HLA system, 2004. Tissue Antigens (2005) 1.57

HLA matching and cadaver kidney transplant survival in North America: influence of center variation and presensitization. Transplantation (1977) 1.56

Empirical validation of the Essen-Möller probability of paternity. Am J Hum Genet (1986) 1.56

Follow-up study of juvenile chronic polyarthritis with particular reference to histocompatibility antigen W. 27. Ann Rheum Dis (1974) 1.55

Anti-HLA antibodies after solid organ transplantation. Transplantation (2000) 1.54

Impaired in-vitro lymphocyte responses in patients with elevated pentachlorophenol (PCP) blood levels. Arch Environ Health (1995) 1.52

Impact of IgG3 subclass and C1q-fixing donor-specific HLA alloantibodies on rejection and survival in liver transplantation. Am J Transplant (2015) 1.50

A dialysis patient with systemic calciphylaxis exhibiting rapidly progressive visceral ischemia and acral gangrene. Intern Med (1995) 1.49

HL-A antigens and antibody response after influenza A vaccination. Decreased response associated with HL-A type W16. N Engl J Med (1976) 1.49

Preparation of tumor-specific boron compounds. 1. In vitro studies using boron-labeled antibodies and elemental boron as neutron targets. J Med Chem (1972) 1.46

HLA and the inheritance of multiple sclerosis: linkage analysis of 72 pedigrees. Am J Hum Genet (1980) 1.46

Cytotoxins in disease. 3. Antibodies against lymphocytes produced by vaccination. Transplantation (1970) 1.46

HLA genotypic study of insulin-dependent diabetes the excess of DR3/DR4 heterozygotes allows rejection of the recessive hypothesis. Diabetes (1983) 1.45

Deliberate donor-specific blood transfusions prior to living related renal transplantation. A new approach. Ann Surg (1980) 1.45

Higher risk of kidney graft failure in the presence of anti-angiotensin II type-1 receptor antibodies. Am J Transplant (2013) 1.44

Suppression of lymphocyte transformation by aspirin. Lancet (1973) 1.43

Evaluation of HLA matching for CREG antigens in Europe. Transplantation (1999) 1.43

Twins with two different fathers identified by HLA. N Engl J Med (1978) 1.43

Paired kidney exchange is not a solution to ABO incompatibility. Transplantation (1998) 1.43

Reassessing the impact of donor HLA-C genotype on long-term liver transplant survival. Am J Transplant (2009) 1.43

Extremely high association between appearance of HLA antibodies and failure of kidney grafts in a five-year longitudinal study. Am J Transplant (2007) 1.43

HLA DNA typing and transplantation. Immunity (2001) 1.42

LIGHT AND ELECTRON MICROSCOPIC STUDY OF BIOPSIES FROM THIRTY-THREE HUMAN RENAL ALLOGRAFTS AND AN ISOGRAFT 134-212 YEARS AFTER TRANSPLANTATION. Ann N Y Acad Sci (1996) 1.42

HL-A W27--a clue to the diagnosis and pathogenesis of Reiter's syndrome. N Engl J Med (1974) 1.41

Poor kidney-transplant survival in recipients with frozen-blood transfusions or no transfusions. Lancet (1974) 1.40

HLA matching assessed from early graft function. Transplant Proc (1987) 1.40

Nomenclature for factors of the HLA system, 1998. Tissue Antigens (1999) 1.40

Lymphocyte abnormalities in ankylosing spondylitis. Ann Rheum Dis (1977) 1.39

IL-6 independent monocyte/B cell defect in renal transplant recipients with long-term stable graft function. Transplantation (1994) 1.39

Serotyping for homotransplantation. XIX. Experience with an interhospital scheme of cadaver-kidney sharing and tissue typing. JAMA (1969) 1.38

Genetics of four new HL-A specificities in the Caucasian and Negro populations. Transplant Proc (1971) 1.38

Double helices with parallel strands are formed by nuclease-resistant oligo-[alpha]-deoxynucleotides and oligo-[alpha]-deoxynucleotides covalently linked to an intercalating agent with complementary oligo-[beta]-deoxynucleotides. J Mol Biol (1987) 1.38

Analyses of the UNOS Scientific Renal Transplant Registry at three years--early events affecting transplant success. Transplantation (1992) 1.37

HLA-B14 antigen and postencephalitic Parkinson's disease. Their association in an American-Jewish ethnic group. Arch Neurol (1980) 1.37

Group-specific human granulocyte antigens on a chronic myelogenous leukemia cell line with a Philadelphia chromosome marker. Blood (1977) 1.35

Flow cytometric detection of HLA antibodies using a spectrum of microbeads. Hum Immunol (1999) 1.34

Cross-reactions between streptococcal M proteins and human transplantation antigens. Science (1970) 1.33

Prospective registry-based observational cohort study of the long-term risk of malignancies in renal transplant patients treated with mycophenolate mofetil. Am J Transplant (2005) 1.33

Presensitization and kidney transplant failures. Postgrad Med J (1971) 1.33

A new microcellular cytotoxicity test based on calcein AM release. Hum Immunol (1993) 1.32

Serotyping for homotransplantation. IX. Evaluation of leukocyte antigen matching with the clinical course and rejection types. Transplantation (1967) 1.32

Sjögren's syndrome association with HLA-Dw3. N Engl J Med (1977) 1.32

Serotyping for homotransplantation. XVI. Analysis of kidney transplants from unrelated donors. N Engl J Med (1968) 1.31